Services

Discover ImaBiotech's various offers using cutting-edge Multimaging technology which combines Quantitative Mass Spectrometry Imaging and histology techniques to improve:

• Biomarker Disovery and Evaluations for many applications (Disease state or progression evaluations, efficacy or toxicity evaluations)
• Target engagement by QMSI allows the localization of the drug, metabolites and their pharmacological target without labelling
• Pharmacokinetics and Pharmacodynamics by QMSI provides drug and metabolites distribution with companion biomarkers at whole body or cellular levels
• Toxicity studies with QMSI identify the relation between drug, metabolites and toxicity at cellular levels, improve the chemical compounds and avoid NoGo decision at later stage Phase II